Parafluorofentanyl Stats & Data

Parafluorofentanyl was originally developed by Janssen Pharmaceutica during the 1960s as part of their extensive research into fentanyl analogs. The compound appeared briefly on the illicit United States market in the early 1980s, notably predating the introduction of the Federal Analog Act, which represented the first legislative attempt to control entire families of drugs based on structural similarity rather than scheduling each compound individually as it emerged. Fentanyl analogs as a class have been responsible for thousands of fatalities across Europe and former Soviet republics since a resurgence in use that originated in Estonia during the early 2000s, with novel derivatives continuing to appear on illicit markets. In 2020, the United States Drug Enforcement Administration issued warnings regarding the increasing prevalence of parafluorofentanyl specifically in Arizona. Despite these developments, the substance remains relatively rare and poorly characterized in the scientific literature.